16 March 2015
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, has today been informed of the following disclosure in accordance with the requirements of Rule 17 (disclosure of miscellaneous information). On 16 March 2015, administrators were appointed to Hume Capital Securities plc, a company of which Jonathan Freeman, a Non-Executive Director of Futura, was a non-executive director since March 2012.
For further information please contact:
Aubrey Powell / Liz Yong
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Mark Court / Sophie Wills /
Stephanie Watson / Tilly Abraham
Tel: +44 (0) 20 7466 5000
Notes to editors:
About Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.